When a baby’s life was threatened by a rare pediatric cancer that would not respond to surgery or chemotherapy, doctors successfully shrank the tumor by 90 percent using an experimental treatment, according to a new study. The now-20-month-old girl achieved the remarkable improvement by receiving a drug called LOXO-101 that was being tested on adults, researchers reported. Read full article